Market Place
Sourcing Support
Acacia Research Reports Third Quarter 2022 Financial Results
10 Nov 2022 //
BUSINESSWIRE
Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group
09 Jun 2022 //
GLOBENEWSWIRE
Court Sanction of the Scheme of Arrangement
07 Jun 2022 //
GLOBENEWSWIRE
Acacia Pharma Results of Court and General Meeting
20 May 2022 //
GLOBENEWSWIRE
Publication of Scheme Document
27 Apr 2022 //
GLOBENEWSWIRE
Acacia Pharma Group plc - Total Number of Voting Rights and Capital
31 Mar 2022 //
GLOBENEWSWIRE
Acacia Pharma to Postpone Publication of its Results for the Full Year 2021
30 Mar 2022 //
GLOBENEWSWIRE
Eagle Pharmaceuticals signs deal to acquire UK-based Acacia Pharma
30 Mar 2022 //
PHARMACEUTICAL-TECHNOLOGY
Acacia Pharma Announces CFO Gary Gemignani is to Leave the Company
23 Mar 2022 //
GLOBENEWSWIRE
Acacia Pharma Issues Ordinary Shares to its Employee Benefit Trust
20 Dec 2021 //
GLOBENEWSWIRE
Acacia Pharma’s new cancer care injection approved in Europe
29 Sep 2021 //
PHARMAFILE
Acacia Announces Submission &Validation of MKT Authorization for BARHEMSYS®
29 Sep 2021 //
GLOBENEWSWIRE
Acacia Pharma Announces Initiation of Pivotal Study of Byfavo®
16 Sep 2021 //
GLOBENEWSWIRE
Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update
18 Feb 2021 //
GLOBENEWSWIRE
Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural
28 Jan 2021 //
GLOBENEWSWIRE
Acacia Announces Amendment of its Investment Agreement with Cosmo
15 Dec 2020 //
GLOBENEWSWIRE
Acacia Pharma completes drawdown from €25 million loan facility
09 Oct 2020 //
GLOBENEWSWIRE
BYFAVO™ (remimazolam) Clears Final Hurdle on Path to Commercial Launch in the US
06 Oct 2020 //
PRESSRELEASE
Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies
16 Jul 2020 //
GLOBENEWSWIRE
Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo NV
15 Jul 2020 //
GLOBENEWLSWIRE
Acacia snaps up Woodford biotech stakes in £224m deal
04 Jun 2020 //
CITYAM
Acacia Pharma`s twice spurned drug finally makes the FDA cut
28 Feb 2020 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.